Skip to content

Clinical trials

Respiratory Insufficiency trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Insufficiency Phase: Not applicable Country / region: United States Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20064
20074
20083
20092
20104
20118
20126
20136
20148
20157
201610
20179
201810
20197
202015
20217
20226
202311
202413
20252
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Terminated28
Recruiting18
Active, not recruiting9
Unknown status9
Withdrawn8
Not yet recruiting6
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital9
Johns Hopkins University5
Rush University Medical Center5
Vanderbilt University Medical Center5
Vapotherm, Inc.5
Wake Forest University Health Sciences5
Beth Israel Deaconess Medical Center4
University of Chicago4
University of Utah4
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Insufficiency157
Critical Illness17
Respiratory Distress Syndrome13
COVID-199
Pulmonary Disease, Chronic Obstructive7
Dyspnea6
Sepsis6
Wounds and Injuries6
Heart Arrest5
Pneumonia5

Trials

Showing 1 to 25 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.